Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 7451-7500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06500845
Assessment of Marginal and Internal Fit of High Performance Polymer PEEK Endocrown Using Two Preparation Designs
NA
Recruiting
24 participants
Started: Sep 17, 2025 · Completed: Jun 1, 2026
3 conditions
1 sponsor
1 location
NCT07053891
LUPKYNIS Drug-use Results Survey
N/A
Recruiting
400 participants
Started: Sep 17, 2025 · Completed: Jun 30, 2032
1 condition
1 sponsor
1 location
NCT06928116
Heat thErapy And mobiLity in COVID-19 Survivors
NA
Recruiting
99 participants
Started: Sep 17, 2025 · Completed: Aug 31, 2029
1 condition
2 sponsors
1 location
NCT07118241
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
PHASE2
Recruiting
80 participants
Started: Sep 17, 2025 · Completed: Aug 31, 2026
1 condition
1 sponsor
6 locations
NCT06194461
LTFU for All Cell and Gene Therapy Studies
N/A
Not yet recruiting
64 participants
Started: Sep 17, 2025 · Completed: Nov 29, 2041
2 conditions
1 sponsor
25 locations
NCT07162922
Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomy
NA
Recruiting
76 participants
Started: Sep 17, 2025 · Completed: Jan 1, 2026
3 conditions
1 sponsor
1 location
NCT07110519
Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
EARLY_PHASE1
Recruiting
10 participants
Started: Sep 17, 2025 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT07045311
JS207 Combination Therapy in Triple-negative Breast Cancer
PHASE2
Recruiting
80 participants
Started: Sep 17, 2025 · Completed: Mar 22, 2029
1 condition
1 sponsor
16 locations
NCT07118254
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
PHASE2
Active, not recruiting
15 participants
Started: Sep 17, 2025 · Completed: May 31, 2026
1 condition
1 sponsor
3 locations
NCT07195968
Comparative Analysis of NTG-Pd/Pa and Saline-Pd/Pa (CANS)
N/A
Enrolling by invitation
50 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2029
1 condition
3 sponsors
3 locations
NCT07192458
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
PHASE2
Recruiting
60 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
PHASE3
Recruiting
942 participants
Started: Sep 17, 2025 · Completed: Jan 22, 2030
1 condition
1 sponsor
13 locations
NCT07169578
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3
Recruiting
800 participants
Started: Sep 17, 2025 · Completed: Jun 7, 2028
1 condition
1 sponsor
11 locations
NCT07023835
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
PHASE2
Recruiting
240 participants
Started: Sep 17, 2025 · Completed: Oct 31, 2028
1 condition
1 sponsor
15 locations
NCT07195162
Validating and Evaluating the Pain Medicine Digital Workflow Algorithm (PGS 1.0)
N/A
Recruiting
200 participants
Started: Sep 17, 2025 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT07012135
Deciphering Preserved Autonomic Function After Multiple Sclerosis
NA
Recruiting
13 participants
Started: Sep 17, 2025 · Completed: Jan 31, 2026
3 conditions
1 sponsor
1 location
NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
PHASE3
Not yet recruiting
561 participants
Started: Sep 17, 2025 · Completed: Mar 31, 2033
1 condition
1 sponsor
0 locations
NCT07188857
Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
N/A
Not yet recruiting
100 participants
Started: Sep 17, 2025 · Completed: Oct 1, 2027
3 conditions
2 sponsors
0 locations
NCT07179224
EEG Changes After rTMS Stimulation
NA
Recruiting
15 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06716502
A New Portable Device for Non-invasive Ventilatory Support
NA
Recruiting
50 participants
Started: Sep 17, 2025 · Completed: Nov 19, 2025
2 conditions
3 sponsors
3 locations
NCT07053085
A Study of Surgery and Radiotherapy in People With Breast Cancer
PHASE2
Recruiting
162 participants
Started: Sep 17, 2025 · Completed: Sep 17, 2029
2 conditions
2 sponsors
7 locations
NCT06908252
MAPS PrEP Van Study
PHASE4
Recruiting
20 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT07161713
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
NA
Recruiting
100 participants
Started: Sep 17, 2025 · Completed: Sep 30, 2027
11 conditions
1 sponsor
1 location
NCT07200986
Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
PHASE1
Recruiting
218 participants
Started: Sep 17, 2025 · Completed: Mar 31, 2026
1 condition
1 sponsor
5 locations
NCT07122973
Topographical Distribution of Itch and Pain Receptors
NA
Recruiting
30 participants
Started: Sep 17, 2025 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT06989957
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
PHASE1
Recruiting
40 participants
Started: Sep 17, 2025 · Completed: Aug 31, 2029
1 condition
2 sponsors
1 location
NCT06959810
Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
NA
Not yet recruiting
55 participants
Started: Sep 16, 2025 · Completed: Sep 15, 2028
3 conditions
3 sponsors
1 location
NCT06420531
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
NA
Recruiting
486 participants
Started: Sep 16, 2025 · Completed: Aug 30, 2030
1 condition
1 sponsor
4 locations
NCT07113561
Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance
NA
Recruiting
60 participants
Started: Sep 16, 2025 · Completed: Dec 31, 2027
1 condition
5 sponsors
1 location
NCT07122895
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
PHASE2
Recruiting
90 participants
Started: Sep 16, 2025 · Completed: Mar 31, 2030
1 condition
2 sponsors
1 location
NCT07001891
Functional Connectivity of the Interoceptive Network in RLS
NA
Recruiting
30 participants
Started: Sep 16, 2025 · Completed: Oct 31, 2026
1 condition
2 sponsors
1 location
NCT07212101
Sleep in Collegiate Baseball Players
NA
Enrolling by invitation
40 participants
Started: Sep 16, 2025 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT06589245
Inhaled Ciclesonide Study in Preterm Infants
PHASE1
Recruiting
30 participants
Started: Sep 16, 2025 · Completed: Aug 31, 2026
1 condition
3 sponsors
1 location
NCT07160335
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
PHASE1
Not yet recruiting
174 participants
Started: Sep 16, 2025 · Completed: Mar 27, 2028
3 conditions
1 sponsor
0 locations
NCT06749145
Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study
NA
Enrolling by invitation
410 participants
Started: Sep 16, 2025 · Completed: Aug 31, 2028
1 condition
4 sponsors
3 locations
NCT07093749
Perspectives on Antibiotics and Tracking Symptoms in Children
NA
Recruiting
300 participants
Started: Sep 16, 2025 · Completed: Aug 31, 2026
7 conditions
2 sponsors
1 location
NCT06890403
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
NA
Recruiting
6,000 participants
Started: Sep 16, 2025 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT07184229
Effect of Motivational Counseling on the Intention to Use Modern Contraceptive Methods
NA
Not yet recruiting
120 participants
Started: Sep 16, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07070128
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
N/A
Not yet recruiting
800 participants
Started: Sep 16, 2025 · Completed: Aug 11, 2026
1 condition
1 sponsor
2 locations
NCT06181630
A Lactation Study in Women Receiving Treatment With Ozanimod
PHASE4
Recruiting
16 participants
Started: Sep 16, 2025 · Completed: Dec 16, 2026
2 conditions
1 sponsor
1 location
NCT07181980
Intercostal Mulligan Moblization Post Mastectomy
NA
Not yet recruiting
40 participants
Started: Sep 16, 2025 · Completed: Sep 16, 2026
1 condition
1 sponsor
1 location
NCT07151378
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
PHASE3
Not yet recruiting
150 participants
Started: Sep 16, 2025 · Completed: Sep 22, 2030
1 condition
1 sponsor
1 location
NCT07104162
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
PHASE1
Recruiting
40 participants
Started: Sep 16, 2025 · Completed: Dec 23, 2026
1 condition
3 sponsors
2 locations
NCT07015996
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
PHASE2
Not yet recruiting
62 participants
Started: Sep 16, 2025 · Completed: Sep 16, 2028
1 condition
4 sponsors
10 locations
NCT07207707
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
PHASE1
Recruiting
78 participants
Started: Sep 16, 2025 · Completed: Mar 31, 2027
1 condition
1 sponsor
5 locations
NCT07037758
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
PHASE1
Recruiting
380 participants
Started: Sep 16, 2025 · Completed: Jan 4, 2031
1 condition
2 sponsors
4 locations
NCT07215715
US Benchmarking Clinical Study
N/A
Recruiting
150 participants
Started: Sep 16, 2025 · Completed: Jul 31, 2026
5 conditions
4 sponsors
3 locations
NCT07218445
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
PHASE4
Active, not recruiting
40 participants
Started: Sep 16, 2025 · Completed: Sep 18, 2027
2 conditions
1 sponsor
1 location
NCT07105891
Optimization of Oocyte Warming Protocols
NA
Active, not recruiting
399 participants
Started: Sep 16, 2025 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT07175623
Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients
NA
Recruiting
60 participants
Started: Sep 16, 2025 · Completed: Dec 30, 2025
3 conditions
1 sponsor
2 locations
Previous
1
More pages
147
148
149
150
151
152
153
More pages
2369
Next